Tineke Vandenbroucke.

Cancer treatment during being pregnant exposes the fetus to potentially toxic substances that influence cell division. Chemotherapeutic medications can cross the placenta in varying quantities.1,2 Data on fetal effects of maternal tumor treatment are based mainly on retrospective cohort research.3-6 From our 10-year experience, it would appear that the limited option of safety data can influence therapeutic decision making, which results in a higher threshold for initiating chemotherapy and a low threshold for terminating being pregnant.This research group led by Dr. Chun-Xia Yang collected a cohort of 191 patients and 198 settings in Yanting, a rural county of Sichuan Province in China. Each participant completed a questionnaire and supplied 1 mL of blood, which gave the united team enough information regarding environmental and genetic factors on esophageal cancer. Related StoriesCornell biomedical engineers develop 'super natural killer cells' to destroy cancers cells in lymph nodesMD Anderson study reveals why chemotherapy medicines not effective for most pancreatic cancer patientsOvarian cancers patients with a history of oral contraceptive use have better outcomesThis research reported that the ALDH2*1/*2 and ADH2*1 allele potentiate the carcinogenic effects of alcohol on the esophagus, and the two genotypes could modulate individual differences in alcohol-oxidizing capacity and consuming behavior.